VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the publication of a new clinical manuscript suggesting that the Nu.Q® H3.1 biomarker has ...

Molecular Diagnostics in Cancer is rapidly advancing with segments like Cancer Companion Diagnostics reshaping the industry. The report profiles over 140 companies and highlights trends such as ...

Frimpong has already been brought in from Bayer Leverkusen in a £29.5m deal, while Wirtz is set to make the same trip in a ...

The worldwide race for Hamza Igamane is underway with the Daily Record leading the illusion that the striker is hot property.